Evidence map›Paper›PMID 30166980›Full record

ArticleFrontiers in microbiology2018

Early

M Gabriela Libisch, Paula Faral-Tello, Nisha J Garg, Rafael Radi, Lucía Piacenza, Carlos Robello

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Cardiomyocyte infection byFrontiers in cellular and infection microbiology · 2023
    Article
  4. Comparative microRNA profiling ofFrontiers in cellular and infection microbiology · 2023
    Article
  5. Different Transcriptomic Response toFrontiers in cellular and infection microbiology · 2022
    Article
  6. Review
  7. Article
  8. Review
  9. Transcriptional Studies onFrontiers in cellular and infection microbiology · 2021
    Review
  10. International journal of molecular sciences · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

M Gabriela LibischLaboratory of Host-Pathogen Interactions-UBM, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Paula Faral-TelloLaboratory of Host-Pathogen Interactions-UBM, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Nisha J GargDepartment of Microbiology and Immunology, The University of Texas Medical Branch, Galveston, TX, United States.
Rafael RadiDepartamento de Bioquímica, Center for Free Radical and Biomedical Research, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Lucía PiacenzaDepartamento de Bioquímica, Center for Free Radical and Biomedical Research, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Carlos RobelloLaboratory of Host-Pathogen Interactions-UBM, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Universidad de la República · UYInstitut Pasteur de Montevideo · UYThe University of Texas Medical Branch at Galveston · US

Funding

Medical Research Council MR/P027989/1
6 · The paper itself

Abstract

Chagasic chronic cardiomyopathy is one of the most frequent and severe manifestations of Chagas disease, caused by the parasite

Indexed as

Chagas diseasechronic chagasic cardiopathyearly response to infectionhost–pathogenmitochondrial function

Identifiers

PMID30166980
PMCPMC6106620
OpenAlexW2887847068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.